sumatriptan has been researched along with 1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, MS; Jelley, RA; MacLeod, AM; Matassa, VG; Rathbone, D; Reeve, AJ; Stanton, JA; Sternfeld, F; Street, LJ; Watt, AP | 1 |
| Beer, MS; Chambers, MS; Goodacre, S; Hobbs, SC; Hunt, P; Jelley, RA; MacLeod, AM; Matassa, VG; Rathbone, D; Reeve, AJ; Stanton, JA; Sternfeld, F; Street, LJ; Watt, AP | 1 |
| Audinot, V; Millan, MJ; Moreira, C; Newman-Tancredi, A; Verrièle, L | 1 |
| Choi, SK; Green, D; Ho, A; Klein, U; Marquess, D; Taylor, R; Turner, SD | 1 |
| Hill, RG; Longmore, J; MacLeod, A; Maguire, JJ; Schofield, WN; Street, L | 1 |
5 other study(ies) available for sumatriptan and 1-(3-(5-(1,2,4-triazol-4-yl)-1h-indol-3-yl)propyl)-4-(2-(3-fluorophenyl)ethyl)piperazine
| Article | Year |
|---|---|
Selective, orally active 5-HT1D receptor agonists as potential antimigraine agents.
Topics: Administration, Oral; Animals; Biological Availability; Migraine Disorders; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin Receptor Agonists; Species Specificity | 1997 |
3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
Topics: Administration, Oral; Animals; Biological Availability; CHO Cells; Cricetinae; Indoles; Male; Migraine Disorders; Models, Molecular; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Recombinant Proteins; Serotonin Receptor Agonists; Structure-Activity Relationship | 1999 |
Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.
Topics: Animals; Binding, Competitive; Cell Membrane; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Ligands; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; Serotonin Antagonists; Sulfur Radioisotopes; Tritium | 2000 |
Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.
Topics: Animals; Benzamides; CHO Cells; Cricetinae; Cricetulus; Dimerization; In Vitro Techniques; Indoles; Ligands; Muscle Contraction; Muscle, Smooth, Vascular; Rabbits; Radioligand Assay; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptor, Serotonin, 5-HT1F; Receptors, Serotonin; Saphenous Vein; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists; Structure-Activity Relationship | 2008 |
Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
Topics: Adult; Analysis of Variance; Coronary Vessels; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Indoles; Male; Middle Aged; Piperazines; Potassium Chloride; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT1D; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Vasoconstriction | 2000 |